Work

Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis

Year: 2021

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Metabolism

DOI: 10.1016/j.metabol.2021.154780

Authors: Ashwini Arvind, Zoe N. Memel, Lisa L. Philpotts, Hui Zheng, Kathleen E. Corey, Tracey G. Simon

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Novartis, American Association for the Study of Liver Diseases, Harvard University Center for AIDS Research, Dana-Farber/Harvard Cancer Center, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G3123888880, Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk, Aspirin and Novel Lipid Mediators in Nonalcoholic Fatty Liver Disease

OpenAlex ID: W3155508181

FWCI: 0.708

Cites: 58

Cited by: 39

Related to: 10